LBA-2: A New Cause of Hereditary and Acquired Erythrocytosis
At ASH 2024, François Girdon and Betty Gardie presented a Late Breaking Abstract on a new cause of erythrocytosis. The study aimed to investigate unexplained cases of hereditary and acquired erythrocytosis with normal erythropoietin (EPO) levels. The team identified a hepatic-like variant of EPO with enhanced activity, resembling fetal liver-derived EPO, as the driver of red blood cell overproduction. These findings suggest a need for qualitative EPO analysis in clinical practice to improve the diagnosis of idiopathic erythrocytosis.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in